These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7515347)

  • 1. Clinical analysis and evaluation of the results of adjuvant treatment (radiotherapy and chemotherapy) in ovarian carcinoma.
    Pietrzak K; Sablińska B; Zieliński J
    Eur J Gynaecol Oncol; 1993; 14 Suppl():133-9. PubMed ID: 7515347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Fountzilas G; Aravantinos G; Kalofonos C; Efstathiou H; Farmakis D; Skarlos D; Pavlidis N; Economopoulos T; Dimopoulos MA
    Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selecting postoperative chemotherapy regimen and optimizing therapy cycle for stage II-IV ovarian epithelial carcinoma].
    Huang YW; Li YJ; Li MD
    Ai Zheng; 2005 Aug; 24(8):994-7. PubMed ID: 16086880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
    Zhao XD; Zhang Q; Zhang Y
    Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
    Tang L; Zheng M; Xiong Y; Ding H; Liu FY
    Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.
    Young RC; Brady MF; Nieberg RK; Long HJ; Mayer AR; Lentz SS; Hurteau J; Alberts DS
    J Clin Oncol; 2003 Dec; 21(23):4350-5. PubMed ID: 14645424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of an advanced ovarian serous cystadenocarcinoma in pregnancy with cisplatin, adriamycin and cyclophosphamide (CAP) regimen. Case report.
    Ohara N; Teramoto K
    Clin Exp Obstet Gynecol; 2000; 27(2):123-4. PubMed ID: 10968352
    [No Abstract]   [Full Text] [Related]  

  • 10. A systematic overview of chemotherapy effects in ovarian cancer.
    Högberg T; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of postoperative radiotherapy with postoperative chemotherapy in stage II-IV ovarian cancer patients.
    Menczer J; Ben-Baruch G; Modan M; Brenner J; Brenner H
    Gynecol Oncol; 1984 Feb; 17(2):207-12. PubMed ID: 6546732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients.
    Onda T; Yoshikawa H; Yasugi T; Mishima M; Nakagawa S; Yamada M; Matsumoto K; Taketani Y
    Cancer; 1998 Oct; 83(8):1555-60. PubMed ID: 9781949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tolerance and role of irradiation in the treatment of epithelial cancer of the ovary].
    Quétin P; Marchal C; Hoffstetter S; Cutuli B; Beckendorf V; Lapeyre M; Peiffert D; Bey P
    Cancer Radiother; 1998; 2(4):366-74. PubMed ID: 9755750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
    Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of topotecan and cisplatin as first line chemotherapy in epithelial ovarian cancer].
    Meng LH; Kong BH; Zhang YZ; Yang XS; Wang LJ; Su SL; Jiang J; Cui BX; Wang B
    Zhonghua Fu Chan Ke Za Zhi; 2007 Oct; 42(10):683-7. PubMed ID: 18241544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.
    Mundt AJ; McBride R; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1145-53. PubMed ID: 11483323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors.
    Shibata K; Kikkawa F; Mika M; Suzuki Y; Kajiyama H; Ino K; Mizutani S
    Int J Gynecol Cancer; 2003; 13(5):587-92. PubMed ID: 14675340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of optimal debulking in advanced stage serous carcinoma of the uterus.
    Moller KA; Gehrig PA; Van Le L; Secord AA; Schorge J
    Gynecol Oncol; 2004 Jul; 94(1):170-4. PubMed ID: 15262137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant platinum-based chemotherapy in patients with epithelial ovarian cancer: prognostic factors and final outcome.
    Grivas A; Lianos E; Internos I; Papaxoinis G; Tselepatiotis E; Ziras N; Athanasiou AE
    J BUON; 2010; 15(4):647-51. PubMed ID: 21229624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment and prognostic factors of epithelial ovarian cancer].
    Wei L; Qian H; Li W
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):476-9. PubMed ID: 9639741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.